VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 37 filers reported holding VERONA PHARMA PLC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,226,000 | -63.1% | 120,000 | -82.0% | 0.17% | -63.8% |
| Q1 2022 | $3,325,000 | -38.2% | 666,339 | -16.8% | 0.47% | -20.6% |
| Q4 2021 | $5,384,000 | +22.6% | 801,256 | 0.0% | 0.59% | +60.4% |
| Q3 2021 | $4,391,000 | -16.2% | 801,256 | 0.0% | 0.37% | +4.2% |
| Q2 2021 | $5,240,000 | -21.8% | 801,256 | 0.0% | 0.35% | -31.1% |
| Q1 2021 | $6,699,000 | -7.4% | 801,256 | -22.5% | 0.51% | -19.9% |
| Q4 2020 | $7,235,000 | +15.9% | 1,033,603 | +3.4% | 0.64% | +4.7% |
| Q3 2020 | $6,240,000 | – | 1,000,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |